Home/Structure Therapeutics/Ming (Mark) Liu, Ph.D.
M(

Ming (Mark) Liu, Ph.D.

Chief Scientific Officer

Structure Therapeutics

Structure Therapeutics Pipeline

DrugIndicationPhase
GSBR-1290ObesityPhase 2
ANPA-0073Pulmonary Arterial Hypertension (PAH)Preclinical
LTSE-2578ObesityPreclinical